Autolus Therapeutics
Latest round
- Series C
Last raised
- Sep 2017
Total raised
- $180M
Investors
- 6
About Autolus Therapeutics
Founded in 2014 by Martin Pule and based in London, UK, Autolus Therapeutics plc operates in two geographic regions, the United Kingdom and the United States. Autolus works with research institutions and business partners to create and distribute programmed T cell product candidates to patients. The company's technology offers to reprogram T-cells into targeting tumor cells in cancer patients. The company's clinical-stage pipeline comprises five programs: AUTO1, AUTO1/22, AUTO3, AUTO4, and AUTO6. AUTO1 was published in Nature Medicine. AUTO2 is a two-targeted programmed T cell therapy used to treat relapsed or refractory multiple myeloma. AUTO3 is a dual-targeting programmed T cell therapy used to treat relapsed or refractory DLBCL. AUTO4 is a programmed T cell therapy that is used to treat peripheral T-cell lymphoma. AUTO6 is a programmed T cell therapy that is used to treat neuroblastoma. The company plans to use the funds for the advancement of its obecabtagene autoleucel.
Who invested in Autolus Therapeutics
6 investors across 3 rounds
See all investors in Autolus Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Autolus Therapeutics
Who invested in Autolus Therapeutics?
Autolus Therapeutics has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Autolus Therapeutics raised?
Autolus Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Autolus Therapeutics last raise money?
Autolus Therapeutics's most recent round on record is a Series C, in Sep 2017.
What does Autolus Therapeutics do?
Founded in 2014 by Martin Pule and based in London, UK, Autolus Therapeutics plc operates in two geographic regions, the United Kingdom and the United States.
Where is Autolus Therapeutics headquartered?
Autolus Therapeutics is headquartered in London, UK.
Which VCs invest in companies like Autolus Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Autolus Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Autolus Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.